Microbiome forensics is the use of microbial communities to analyse questions of forensic science: Who has touched this item? Where has the body been? How long has the person been
Microbiome forensics is the use of microbial communities to analyse questions of forensic science: Who has touched this item? Where has the body been? How long has the person been
Herbert Smith Freehills Kramer (HSF Kramer) is proud to have advised Australian Unity Limited (Australian Unity) on its recent capital raising, comprising a A$160 million wholesale placement and a A$49.8
Sidley represented RoundTable Healthcare Partners in connection with the sale of its interest in Designs for Health, a provider of premium nutritional products and education for health professionals. During its
Latham & Watkins has advised the initial purchasers in connection with the green bond offering of €775 million 4.25% senior notes due 2030 by Public Power Corporation S.A. The proceeds
Herbert Smith Freehills Kramer is proud to have acted for HOCHTIEF Aktiengesellschaft (HOCHTIEF) in relation to its cornerstone equity investment in Vulcan Energy Resources Limited (Vulcan Energy). This investment forms
Clerq, the next-generation payments platform for high-ticket transactions, has announced that it has secured US$21 million in capital to power the future of payments. The funding includes a US$12 million
October 23, 2025 Global law firm Dentons has advised CGI, one of the world’s largest independent IT and business consulting services firms, on entering into an agreement to acquire Comarch
When you’re involved in a car crash, everything gets complicated until after you’ve successfully pursued compensation and recovered from your injuries. Immediately after the accident, you’re left with accumulating bills,
Baker McKenzie advises KBC Securities, part of the KBC Group, on the formation and regulatory aspects of a joint venture with Van Lanschot Kempen Investment Banking, combining their equity research,
MapLight Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, has announced the pricing of its initial public offering